UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. )*
ALLOS THERAPEUTICS, INC.
------------------------
(Name of Issuer)
COMMON STOCK, PAR VALUE $.01 PER SHARE
--------------------------------------
(Title of Class of Securities)
019777101
---------
(CUSIP Number)
APRIL 24, 2002
--------------
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[_] Rule 13d-1(b)
[X] Rule 13d-1(c)
[_] Rule 13d-1(d)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the reminder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
CUSIP NO. 019777101 Schedule 13G Page 2 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus-Soros BioPharmaceutical Fund, LP
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 2,500,000
Beneficially (6) Shared Voting Power 0
Owned by Each (7) Sole Dispositive Power 2,500,000
Reporting Person (8) Shared Dispositive Power 0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person PN
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 3 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus-Soros Partners, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 2,500,000
Beneficially (6) Shared Voting Power 0
Owned by Each (7) Sole Dispositive Power 2,500,000
Reporting Person (8) Shared Dispositive Power 0
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 4 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus BioTech Fund Partners, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 2,500,000
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 2,500,000
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 5 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person SFM Participation, LP
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 2,500,000
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 2,500,000
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person PN
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 6 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person SFM AH, Inc.
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 2,500,000
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 2,500,000
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person CO
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 7 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseus EC, L.L.C.
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 224,600 (1)
Beneficially (6) Shared Voting Power 2,500,000 (1)
Owned by Each (7) Sole Dispositive Power 224,600 (1)
Reporting Person (8) Shared Dispositive Power 2,500,000 (1)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,724,600 (1)
-------------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
______
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 10.6%
-----
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
--------------
1 See Item 4 herein.
CUSIP NO. 019777101 Schedule 13G Page 8 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Perseuspur, LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 224,600 (1)
Beneficially (6) Shared Voting Power 2,500,000 (1)
Owned by Each (7) Sole Dispositive Power 224,600 (1)
Reporting Person (8) Shared Dispositive Power 2,500,000 (1)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,724,600 (1)
-------------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 10.6%
-----
--------------------------------------------------------------------------------
12. Type of Reporting Person OO
--------------------------------------------------------------------------------
--------------
1 See Item 4 herein.
CUSIP NO. 019777101 Schedule 13G Page 9 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Frank H. Pearl
S.S. or I.R.S. Identifica- (in the capacity described herein)
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization United States
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 475,400 (1)
Beneficially (6) Shared Voting Power 2,500,000 (1)
Owned by Each (7) Sole Dispositive Power 475,400 (1)
Reporting Person (8) Shared Dispositive Power 2,500,000 (1)
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,975,400 (1)
-------------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 11.6%
-----
--------------------------------------------------------------------------------
12. Type of Reporting Person IN
--------------------------------------------------------------------------------
--------------
1 See Item 4 herein.
CUSIP NO. 019777101 Schedule 13G Page 10 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person George Soros
S.S. or I.R.S. Identifica- (in the capacity described herein)
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 2,500,000
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 2,500,000
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person IA
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 11 of 19
---------
--------------------------------------------------------------------------------
1. Name of Reporting Person Soros Fund Management LLC
S.S. or I.R.S. Identifica-
tion No. of Above Person
--------------------------------------------------------------------------------
2. Check the Appropriate Box (a) [_]
if a Member of a Group (b) [X]
--------------------------------------------------------------------------------
3. S.E.C. Use Only
--------------------------------------------------------------------------------
4. Citizenship or Place of Organization Delaware
--------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power 0
Beneficially (6) Shared Voting Power 2,500,000
Owned by Each (7) Sole Dispositive Power 0
Reporting Person (8) Shared Dispositive Power 2,500,000
--------------------------------------------------------------------------------
9. Aggregate Amount Beneficially Owned by Each Reporting Person
2,500,000
---------
--------------------------------------------------------------------------------
10. Check if the Aggregate Amount in Row (9) Excludes Certain
Shares
X
-----
--------------------------------------------------------------------------------
11. Percent of Class Represented by Amount in Row 9 9.8%
----
--------------------------------------------------------------------------------
12. Type of Reporting Person OO; IA
--------------------------------------------------------------------------------
CUSIP NO. 019777101 Schedule 13G Page 12 of 19
---------
Item 1. (a) NAME OF ISSUER
--------------
Allos Therapeutics, Inc. (the "Company").
(b) ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES
-----------------------------------------------
11080 Circlepoint Road, Suite 200
Westminster, CO 80020
Item 2. (a) NAMES OF PERSONS FILING
-----------------------
This Statement is being filed on behalf of each of the
following persons (collectively, the "Reporting Persons")
(i) Perseus-Soros BioPharmaceutical Fund, LP, a Delaware
limited partnership (the "Purchaser");
(ii) Perseus-Soros Partners, LLC, a Delaware limited
liability company ("PSP GP" and general partner of
Purchaser);
(iii) Perseus BioTech Fund Partners, LLC, a Delaware limited
liability company ("PBFP Partners" and managing member
of PSP GP);
(iv) SFM Participation, LP, a Delaware limited partnership
("SFM Participation" and managing member of PSP GP);
(v) SFM AH, Inc., a Delaware corporation ("SFM AH" and
general partner of SFM Participation);
(vi) Perseus EC, L.L.C., a Delaware limited liability company
("Perseus EC" and managing member of PBFP Partners);
(vii) Perseuspur, LLC, a Delaware limited liability company
("Perseuspur" and member of Perseus EC);
(viii) Mr. Frank H. Pearl ("Mr. Pearl" and sole member of
Perseuspur);
(ix) Mr. George Soros ("Mr. Soros" and sole shareholder of
SFM AH); and
(x) Soros Fund Management LLC, a Delaware limited liability
company ("SFM LLC").
(b) ADDRESS OF PRINCIPAL BUSINESS OFFICE
------------------------------------
The address of the principal business offices of (i)
the Purchaser, (ii) PSP GP, (iii) PBFP Partners, (iv) Perseus
EC, (v) Perseuspur and (vi) Mr. Pearl is 2099 Pennsylvania
Avenue, Suite 900, Washington, DC 20006-1813.
The address of the principal business offices of (i)
SFM Participation, (ii) SFM AH, (iii) Mr. Soros and (iv) SFM LLC
is 888 Seventh Avenue, 33rd Floor, New York, NY 10106.
CUSIP NO. 019777101 Schedule 13G Page 13 of 19
---------
(c) CITIZENSHIP
-----------
(i) Purchaser - a Delaware limited partnership
(ii) PSP GP - a Delaware limited liability company
(iii) PBFP Partners - a Delaware limited liability company
(iv) SFM Participation - a Delaware limited partnership
(v) SFM AH - a Delaware corporation
(vi) Perseus EC - a Delaware limited liability company
(vii) Perseuspur - Delaware limited liability company
(viii)Mr. Pearl - United States
(ix) Mr. Soros - United States
(x) SFM LLC - a Delaware limited liability company
(d) TITLE OF CLASS OF SECURITIES
----------------------------
Common Stock, par value $.01 per share (the "Common Stock" or
"Shares")
(e) CUSIP NUMBER
------------
019777101
Information contained herein concerning SFM Participation,
SFM AH, SFM LLC and Mr. Soros has been provided by SFM LLC. The
Purchaser, PSP GP, PBFP Partners, Perseus EC, Perseuspur and Mr. Pearl
assume no responsibility for such information. Information contained
herein concerning PBFP Partners, Perseus EC, Perseuspur and Mr. Pearl
has been provided by each such Reporting Person. The Purchaser, PSP
GP, SFM Participation, SFM AH, SFM LLC and Mr. Soros assume no
responsibility for such information.
Item 3. This statement is not being filed pursuant to either Rule 13d-1(b) or
13d-2(b) or (c).
Item 4. OWNERSHIP.
---------
(a) AMOUNT BENEFICIALLY OWNED:
--------------------------
Each of the Reporting Persons, other than Mr. Pearl, Perseus
EC and Perseuspur, may be deemed to beneficially own an aggregate of
2,500,000 Shares.
Mr. Pearl may be deemed to beneficially own an aggregate of
2,975,400 Shares as a result of his voting and dispositive power over
the 2,500,000 Shares owned by the Purchaser, an additional 250,800
Shares beneficially owned by Perseus Capital, LLC, a Delaware limited
liability company ("Perseus Capital"), and 224,600 Shares beneficially
owned by Perseus 2000, L.L.C., a Delaware limited liability company
("Perseus 2000"). Perseus EC and Perseuspur may be deemed to
beneficially own an aggregate of 2,724,600 Shares as a result of their
voting and
CUSIP NO. 019777101 Schedule 13G Page 14 of 19
---------
dispositive power over the 2,500,000 Shares owned by the Purchaser and
the 224,600 Shares beneficially owned by Perseus 2000. Perseus Capital
and Perseus 2000 may be deemed to be affiliates of Mr. Pearl, Perseus
EC and Perseuspur.
(b) PERCENTAGE OWNED:
-----------------
Based on calculations made in accordance with Rule 13d-3(d),
and there being 25,640,197 Shares outstanding as of this date, each of
the Reporting Persons, other than Mr. Pearl, Perseus EC and
Perseuspur, may be deemed to beneficially own approximately 9.8% of
the outstanding Common Stock.
Based on calculations made in accordance with Rule 13d-3(d),
and there being 25,640,197 Shares outstanding as of this date, Mr.
Pearl, Perseus EC and Perseuspur may be deemed to beneficially own
approximately 11.6%, 10.6% and 10.6%, respectively, of the outstanding
Common Stock.
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
---------------------------------------------
(i) Each of the Purchaser and PSP GP may be deemed to have sole power
to direct the voting and disposition of the 2,500,000 Shares
beneficially owned by the Purchaser. Each of Mr. Pearl, Perseus EC and
Perseuspur may be deemed to have sole power to direct the voting and
disposition of the 224,600 Shares beneficially owned by Perseus 2000.
Mr. Pearl may be deemed to have sole power to direct the voting and
disposition of the 250,800 Shares beneficially owned by Perseus
Capital.
(ii) By virtue of the relationships between and among the Reporting
Persons as described in Item 2, each of the Reporting Persons, other
than the Purchaser and PSP GP, may be deemed to share the power to
direct the voting and disposition of the 2,500,000 Shares beneficially
owned by the Purchaser.
The Purchaser, PSP GP, PBFP Partners, SFM Participation, SFM AH, Mr.
Soros and SFM LLC disclaim beneficial ownership of the 250,800 and the
224,600 Shares beneficially owned by Perseus Capital and Perseus 2000,
respectively.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS
--------------------------------------------
Not applicable.
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON
---------------------------------------------------------------
The partners of the Purchaser have the right to participate in
the receipt of dividends from, or proceeds from the sale of, the
securities held for the
CUSIP NO. 019777101 Schedule 13G Page 15 of 19
---------
account of the Purchaser in accordance with their ownership interests
in the Purchaser.
Item 7. IDENTIFICATION AND CLASSIFICATION OF SUBSIDIARY WHICH ACQUIRED THE
------------------------------------------------------------------
SECURITY BEING REPORTEDON BY THE PARENT HOLDING COMPANY
-------------------------------------------------------
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP
---------------------------------------------------------
Not applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP
------------------------------
Not applicable.
Item 10. CERTIFICATION
-------------
By signing below we certify that, to the best of our
knowledge and belief, the securities referred to above were not
acquired and are not held for the purpose of or with the effect of
changing or influencing the control of the issuer of the securities
and were not acquired and are not held in connection with or as a
participant in any transaction having that purpose or effect.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
CUSIP NO. 019777101 Schedule 13G Page 16 of 19
---------
SIGNATURES
After reasonable inquiry and to the best of our knowledge and belief,
the undersigned certify that the information set forth in this statement is
true, complete and correct.
Dated as of May 6, 2002
PERSEUS-SOROS BIOPHARMACEUTICAL FUND, LP
By: Perseus-Soros Partners, LLC,
General Partner
By: SFM Participation, LP,
Managing Member
By: SFM AH, Inc.
General Partner
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
PERSEUS-SOROS PARTNERS, LLC
By: SFM Participation, LP
Managing Member
By: SFM AH, Inc.
General Partner
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
CUSIP NO. 019777101 Schedule 13G Page 17 of 19
---------
PERSEUS BIOTECH FUND PARTNERS, LLC
By: Perseuspur EC, L.L.C.
Managing Member
By: Perseuspur, LLC
Member
By: /s/ Rodd Macklin
--------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
PERSEUS EC, L.L.C.
By: Perseuspur, LLC
Member
By: /s/ Rodd Macklin
--------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
PERSEUSPUR, LLC
By: /s/ Rodd Macklin
--------------------------------
Name: Rodd Macklin
Title: Secretary and Treasurer
MR. FRANK H. PEARL
By: /s/ Frank H. Pearl
--------------------------------
Name: Frank H. Pearl
CUSIP NO. 019777101 Schedule 13G Page 18 of 19
---------
SFM PARTICIPATION, LP
By: SFM AH, Inc.
General Partner
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
SFM AH, INC.
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Secretary
MR. GEORGE SOROS
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Attorney-in-Fact
SOROS FUND MANAGEMENT LLC
By: /s/ Richard D. Holahan, Jr.
--------------------------------
Name: Richard D. Holahan, Jr.
Title: Assistant General Counsel
CUSIP NO. 019777101 Schedule 13G Page 19 of 19
---------
EXHIBIT INDEX
-------------
Exhibit 1. Joint Filing Agreement as required by Rule 13d-1(k)(1)
under the Securities Exchange Act of 1934, as amended.
Exhibit 2. Power of Attorney dated January 15, 2002 appointing each of
Armando T. Belly, Jodye Anzalotta, Maryann Canfield, Sean
Cullinan, Richard D. Holahan, Jr. and Robert Soros as
Attorney-In-Fact for George Soros.